Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2015-02-24Clinical Trial Update: Development of Parkinson's Glove for Detection and Suppression of Hand Tremor [Phase 1]
Phase 1 clinical trial update for a glove-based device designed to detect and suppress hand tremor in Parkinson's disease.
-
CLINICAL_TRIALS research · 2015-02-24Clinical Trial Update: The Study of Rest Tremor Suppression by Using Electrical Muscle Stimulation [Phase 1]
Phase 1 clinical trial evaluating electrical muscle stimulation to suppress rest tremor in Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2015-02-18Clinical Trial Update: Pharmacokinetic Study in Healthy Males [Phase 1]
Phase 1 pharmacokinetic study in healthy male volunteers sponsored by Orion Corporation (Orion Pharma) for a Parkinson's disease program; th…
-
CLINICAL_TRIALS research · 2015-02-16Clinical Trial Update: Whole-body Vibration as a Treatment for Parkinson's Disease [NA]
A clinical trial is evaluating whole-body vibration as a treatment for Parkinson's disease, with the current status not specified.
-
FDA approval · 2015-02-13FDA Approved: BROMOCRIPTINE MESYLATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Bromocriptine Mesylate by Mylan Pharmaceuticals Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-02-13Clinical Trial Update: Internet-CBT (Cognitive Behavioral Therapy) for Depression and Anxiety in Parkinsons Disease [Phase 3]
A Phase 3 trial evaluating Internet-based Cognitive Behavioral Therapy for depression and anxiety in Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2015-02-10Clinical Trial Update: Single Ascending Dose Study of PRX002 in Healthy Subjects [Phase 1]
Phase 1 single ascending dose study of PRX002 in healthy subjects by Prothena completed.
-
CLINICAL_TRIALS trial_result · 2015-02-10Clinical Trial Update: Melatonin for Nocturia in Parkinson's Disease [Phase 2]
A Phase 2 clinical trial is evaluating melatonin for nocturia in Parkinson's disease. The sponsor is University College London, and the curr…
-
CLINICAL_TRIALS trial_result · 2015-02-09Clinical Trial Update: The Effect of Exercise on Individuals With Parkinson's Disease [NA]
A completed clinical trial evaluated the effect of exercise on individuals with Parkinson's disease. The results were posted in February 201…
-
FDA approval · 2015-02-06FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical's supplemental application for a generic carbidopa/levodopa product, enabling marketing for Parkinson's …
-
CLINICAL_TRIALS trial_result · 2015-02-05Clinical Trial Update: The Effect of Rasagiline on Cognition in Parkinson's Disease [Phase 4]
A Phase 4 clinical trial evaluating the effect of rasagiline on cognition in Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2015-02-05Clinical Trial Update: Parkinstep: Automated PD Gait and Balance Assessment for Optimizing DBS
This update notes that the Parkinstep trial, evaluating automated gait and balance assessment in Parkinson's disease patients with deep brai…
-
CLINICAL_TRIALS research · 2015-02-02Clinical Trial Update: The Measurement of Nocturnal Hypokinesia in Parkinson's Disease (PD) Patient Compared With Spouse by Wearable Sensors
A clinical trial update from Chulalongkorn University describes measuring nocturnal hypokinesia in Parkinson's disease patients using wearab…
-
CLINICAL_TRIALS trial_result · 2015-02-02Clinical Trial Update: A Fixed Dose, Dose Response Study for Ropinirole Prolonged Release in Patients With Early Stage Parkinson's Disease [Phase 4]
This clinical trial update reports the completion of a Phase 4 fixed-dose, dose‑response study of ropinirole prolonged release in patients w…
-
CLINICAL_TRIALS trial_result · 2015-01-29Clinical Trial Update: A Study of MK0657 in Parkinson's Disease Patients (0657-006) [Phase 1]
A Phase 1 study of MK0657 in Parkinson's disease patients has completed.
-
CLINICAL_TRIALS research · 2015-01-27Clinical Trial Update: L-dopa Versus Dopamine Agonists After Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease [Phase 2]
A Phase 2 clinical trial updates on the comparison of levodopa versus dopamine agonists after subthalamic nucleus deep brain stimulation in …
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: Development of a Novel 18F-DTBZ PET Imaging as a Biomarker to Monitor Neurodegeneration of PARK6 and PARK8 Parkinsonism [Phase 2]
A Phase 2 study evaluating 18F-DTBZ PET imaging as a biomarker for neurodegeneration in PARK6 and PARK8 Parkinsonism has completed.
-
CLINICAL_TRIALS trial_result · 2015-01-21Clinical Trial Update: Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Different Single Doses of BIA 9-1067 and a Single-dose of Controlled-release 100/25 mg Levodopa/Carbidopa [Phase 1]
Phase 1 PK/PD study assessed pharmacokinetic and pharmacodynamic interactions between three single doses of BIA 9-1067 and a single dose of …
-
FDA approval · 2015-01-16FDA Approved: ENTACAPONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for Entacapone submitted by Sun Pharmaceutical Industries, Inc. The drug is used as an adjunct t…
-
CLINICAL_TRIALS trial_result · 2015-01-16Clinical Trial Update: Safety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's Subjects [Phase 3]
Phase 3 safety and efficacy trial of levodopa-carbidopa intestinal gel in Parkinson's disease completed; results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-01-16Clinical Trial Update: Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects [Phase 3]
A Phase 3 trial evaluated the efficacy, safety, and tolerability of Levodopa-Carbidopa intestinal gel in patients with advanced Parkinson's …
-
CLINICAL_TRIALS trial_result · 2015-01-16Clinical Trial Update: Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects [Phase 3]
Phase 3 trial evaluating levodopa-carbidopa intestinal gel for advanced Parkinson's disease completed, with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-01-16Clinical Trial Update: Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's Disease [Phase 3]
Open-label Phase 3 study of levodopa-carbidopa intestinal gel in advanced Parkinson's disease has completed, with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-01-15Clinical Trial Update: Pharmacokinetic-pharmacodynamic Interaction Between Three Different Single Doses of BIA 9-1067 and a Single-dose of Immediate-release Levodopa/Benserazide [Phase 1]
Phase 1 study assessing pharmacokinetic and pharmacodynamic interactions between three single doses of BIA 9-1067 and a single dose of immed…
-
CLINICAL_TRIALS trial_result · 2015-01-15Clinical Trial Update: Pharmacokinetics of BIA 9-1067 in Subjects With Hepatic Impairment [Phase 1]
Phase 1 pharmacokinetics study of BIA 9-1067 in subjects with hepatic impairment; the study has completed and results were posted in 2015.